Navegar

Colección

Datos Estadísticas

Lista de

dopamine receptor stimulating agent
12
"The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors" (2019) González, B.;Torres, O.V.;Jayanthi, S. (...)Bisagno, V. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 88:222-234
"Cellular and molecular specificity of pituitary gland physiology" (2012) Perez-Castro, C.;Renner, U.;Haedo, M.R. (...)Arzt, E. Physiological Reviews. 92(1):1-38
"Novel medical therapies for pituitary tumors" (2010) Theodoropoulou, M.;Labeur, M.;Paez Pereda, M. (...)Stalla, G.K. Frontiers of Hormone Research. 38:158-164
"Emerging pharmacotherapy of tinnitus" (2009) Langguth, B.; Salvi, R.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 14(4):687-702
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"New aspects in the diagnosis and treatment of cushing disease" (2006) Labeur, M.;Theodoropoulou, M.;Sievers, C. (...)Stalla, G.K. Frontiers of Hormone Research. 35:169-178
"New perspectives in the treatment of cushing's syndrome" (2004) Labeur, M.; Arzt, E.; Stalla, G.K.; Péz-Pereda, M. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 4(4):335-342
"Delayed intracerebral electrode infection after bilateral STN implantation for parkinson's disease" (2001) Merello, M.; Cammarota, A.; Leiguarda, R.; Pikielny, R. Movement Disorders. 16(1):168-170
"The dopamine D 2 , but not D 3 or D 4 , receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice" (1999) Ralph, R.J.;Varty, G.B.;Kelly, M.A. (...)Geyer, M.A. Journal of Neuroscience. 19(11):4627-4633
"Threshold of dopamine content and D1 receptor stimulation necessary for the expression of rotational behavior induced by D2 receptor stimulation under normo and supersensitive conditions" (1997) Dziewczapolski, G.;Mora, M.A.;Menalled, L.B. (...)Gershanik, O.S. Naunyn-Schmiedeberg's Archives of Pharmacology. 355(1):30-35
"Drug-induced parkinsonism in schizophrenic patients: Motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine" (1996) Merello, M.;Starkstein, S.;Petracca, G. (...)Leiguarda, R. Clinical Neuropharmacology. 19(5):439-443